Literature DB >> 12820717

Sialyltransferases in cancer.

F Dall'Olio1, M Chiricolo.   

Abstract

It has long been known that cancer cells often express more heavily sialylated glycans on their surface and that this feature sometimes correlates with invasion. It is now well established that specific sialylated structures, such as the Thomsen-Friedenreich-related antigens, the sialyl Lewis antigens, the sialyl alpha2-6 lactosaminyl structure, the polysialic acid or some gangliosides, can mediate cellular interactions and are altered in cancer cells. This review summarizes the current knowledge on the cancer-associated alterations in sialyltransferase expression which are often at the basis of the deranged expression of sialylated structures.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12820717     DOI: 10.1023/a:1022288022969

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  173 in total

1.  Cloning and expression of the Gal beta 1, 3GalNAc alpha 2,3-sialyltransferase.

Authors:  W Gillespie; S Kelm; J C Paulson
Journal:  J Biol Chem       Date:  1992-10-15       Impact factor: 5.157

2.  Enzymic control of the expression of the X determinant (CD15) in human myeloid cells during maturation: the regulatory role of 6-sialytransferase.

Authors:  P O Skacel; A J Edwards; C T Harrison; W M Watkins
Journal:  Blood       Date:  1991-09-15       Impact factor: 22.113

3.  Systematic nomenclature for sialyltransferases.

Authors:  S Tsuji; A K Datta; J C Paulson
Journal:  Glycobiology       Date:  1996-10       Impact factor: 4.313

4.  Comparison of O-linked carbohydrate chains in MUC-1 mucin from normal breast epithelial cell lines and breast carcinoma cell lines. Demonstration of simpler and fewer glycan chains in tumor cells.

Authors:  K O Lloyd; J Burchell; V Kudryashov; B W Yin; J Taylor-Papadimitriou
Journal:  J Biol Chem       Date:  1996-12-27       Impact factor: 5.157

5.  Low O-acetylation of sialyl-Le(x) contributes to its overexpression in colon carcinoma metastases.

Authors:  B Mann; E Klussmann; V Vandamme-Feldhaus; M Iwersen; M L Hanski; E O Riecken; H J Buhr; R Schauer; Y S Kim; C Hanski
Journal:  Int J Cancer       Date:  1997-07-17       Impact factor: 7.396

6.  Molecular cloning and expression of chick Gal beta 1,3GalNAc alpha 2,3-sialyltransferase.

Authors:  N Kurosawa; T Hamamoto; M Inoue; S Tsuji
Journal:  Biochim Biophys Acta       Date:  1995-05-11

Review 7.  The sialyl-alpha2,6-lactosaminyl-structure: biosynthesis and functional role.

Authors:  F Dall'Olio
Journal:  Glycoconj J       Date:  2000-10       Impact factor: 2.916

8.  Cloning, expression and gene organization of a human Neu5Ac alpha 2-3Gal beta 1-3GalNAc alpha 2,6-sialyltransferase: hST6GalNAcIV.

Authors:  A Harduin-Lepers; D C Stokes; W F Steelant; B Samyn-Petit; M A Krzewinski-Recchi; V Vallejo-Ruiz; J P Zanetta; C Augé; P Delannoy
Journal:  Biochem J       Date:  2000-11-15       Impact factor: 3.857

9.  Characterization of a promoter region supporting transcription of a novel human beta-galactoside alpha-2,6-sialyltransferase transcript in HepG2 cells.

Authors:  D A Aas-Eng; H C Asheim; A Deggerdal; E Smeland; S Funderud
Journal:  Biochim Biophys Acta       Date:  1995-03-14

10.  Cloning of a novel alpha 2,3-sialyltransferase that sialylates glycoprotein and glycolipid carbohydrate groups.

Authors:  H Kitagawa; J C Paulson
Journal:  J Biol Chem       Date:  1994-01-14       Impact factor: 5.157

View more
  104 in total

Review 1.  Simple sugars to complex disease--mucin-type O-glycans in cancer.

Authors:  Matthew R Kudelka; Tongzhong Ju; Jamie Heimburg-Molinaro; Richard D Cummings
Journal:  Adv Cancer Res       Date:  2015-02-07       Impact factor: 6.242

2.  Naturally occurring structural isomers in serum IgA1 o-glycosylation.

Authors:  Kazuo Takahashi; Archer D Smith; Knud Poulsen; Mogens Kilian; Bruce A Julian; Jiri Mestecky; Jan Novak; Matthew B Renfrow
Journal:  J Proteome Res       Date:  2011-12-29       Impact factor: 4.466

3.  Asymmetric synthesis and affinity of potent sialyltransferase inhibitors based on transition-state analogues.

Authors:  Danielle Skropeta; Ralf Schwörer; Tobias Haag; Richard R Schmidt
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

4.  Nuclear magnetic resonance structural characterization of substrates bound to the alpha-2,6-sialyltransferase, ST6Gal-I.

Authors:  Shan Liu; Lu Meng; Kelley W Moremen; James H Prestegard
Journal:  Biochemistry       Date:  2009-12-01       Impact factor: 3.162

Review 5.  Glycosylation in cancer: mechanisms and clinical implications.

Authors:  Salomé S Pinho; Celso A Reis
Journal:  Nat Rev Cancer       Date:  2015-08-20       Impact factor: 60.716

6.  Tissue and serum alpha 2-3- and alpha 2-6-linkage specific sialylation changes in oral carcinogenesis.

Authors:  Manisha H Shah; Shaila D Telang; Pankaj M Shah; Prabhudas S Patel
Journal:  Glycoconj J       Date:  2007-12-25       Impact factor: 2.916

Review 7.  Protein biomarkers in cancer: natural glycoprotein microarray approaches.

Authors:  Jia Zhao; Tasneem H Patwa; David M Lubman; Diane M Simeone
Journal:  Curr Opin Mol Ther       Date:  2008-12

8.  Enhanced susceptibility of nasal polyp tissues to avian and human influenza viruses.

Authors:  Ornpreya Suptawiwat; Pongsakorn Tantilipikorn; Chompunuch Boonarkart; Jate Lumyongsatien; Mongkol Uiprasertkul; Pilaipan Puthavathana; Prasert Auewarakul
Journal:  PLoS One       Date:  2010-09-24       Impact factor: 3.240

9.  alpha2,3-sialyltransferase ST3Gal III modulates pancreatic cancer cell motility and adhesion in vitro and enhances its metastatic potential in vivo.

Authors:  Marta Pérez-Garay; Beatriz Arteta; Lluís Pagès; Rafael de Llorens; Carme de Bolòs; Fernando Vidal-Vanaclocha; Rosa Peracaula
Journal:  PLoS One       Date:  2010-09-01       Impact factor: 3.240

10.  ST3Gal.I sialyltransferase relevance in bladder cancer tissues and cell lines.

Authors:  Paula A Videira; Manuela Correia; Nadia Malagolini; Hélio J Crespo; Dário Ligeiro; Fernando M Calais; Helder Trindade; Fabio Dall'Olio
Journal:  BMC Cancer       Date:  2009-10-07       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.